Literature DB >> 8989520

RPTP delta and the novel protein tyrosine phosphatase RPTP psi are expressed in restricted regions of the developing central nervous system.

L Sommer1, M Rao, D J Anderson.   

Abstract

Transmembrane receptor-type protein tyrosine phosphatases (RPTPs) form a novel and potentially important class of cell regulatory proteins. To identify RPTPs expressed during neural development we have characterized RPTPs transcribed in embryonic day (E)13.5 rat neural tube. Nine different phosphatases, one of which was novel, were identified. We examined the expression of the novel phosphatase, called RPTP psi, and of two other phosphatases, RPTP delta and RPTP mu, whose expression in the developing nervous system has not yet been described in detail. The expression of RPTP mu in small blood capillaries in developing neural tissue is consistent with an involvement in angiogenesis. In contrast, the temporally and spatially regulated expression of RPTP psi and RPTP delta in neuroepithelium suggests a role in early neural development. In the spinal cord, early expression of RPTP delta in the roof plate is followed by its expression in differentiating motor neurons. RPTP psi mRNA is also transiently detectable in the roof plate as well as in floor plate cells. In the telencephalon as well as in the hindbrain at E13.5, the reciprocal expression patterns of RPTP delta and RPTP psi are consistent with a sequential function, RPTP psi exerting its activity in undifferentiated progenitor cells and RPTP delta functioning during neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989520     DOI: 10.1002/(SICI)1097-0177(199701)208:1<48::AID-AJA5>3.0.CO;2-1

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  20 in total

1.  Combinatorial expression patterns of LIM-homeodomain and other regulatory genes parcellate developing thalamus.

Authors:  Y Nakagawa; D D O'Leary
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

2.  Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice.

Authors:  N Uetani; K Kato; H Ogura; K Mizuno; K Kawano; K Mikoshiba; H Yakura; M Asano; Y Iwakura
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 3.  Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system.

Authors:  Smaragda Lamprianou; Sheila Harroch
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Genome-wide association study of severity in multiple sclerosis.

Authors: 
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

Review 5.  Regulation of signaling by protein-tyrosine phosphatases: potential roles in the nervous system.

Authors:  C O Arregui; J Balsamo; J Lilien
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

6.  Receptor protein tyrosine phosphatase gamma is a marker for pyramidal cells and sensory neurons in the nervous system and is not necessary for normal development.

Authors:  Smaragda Lamprianou; Nathalie Vacaresse; Yoshihisa Suzuki; Hamid Meziane; Joseph D Buxbaum; Joseph Schlessinger; Sheila Harroch
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.

Authors:  Vijay Walia; Todd D Prickett; Jung-Sik Kim; Jared J Gartner; Jimmy C Lin; Ming Zhou; Steven A Rosenberg; Randolph C Elble; David A Solomon; Todd Waldman; Yardena Samuels
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

8.  Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.

Authors:  Seok-Kyu Kwon; Jooyeon Woo; Soo-Young Kim; Hyun Kim; Eunjoon Kim
Journal:  J Biol Chem       Date:  2010-02-06       Impact factor: 5.157

Review 9.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

10.  Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.

Authors:  David A Solomon; Jung-Sik Kim; Julia C Cronin; Zita Sibenaller; Timothy Ryken; Steven A Rosenberg; Habtom Ressom; Walter Jean; Darell Bigner; Hai Yan; Yardena Samuels; Todd Waldman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.